Reducing the use of inhaled corticosteroids in mild-moderate COPD: an observational study in east London

Inhaled corticosteroids (ICS) are often prescribed for worsening breathlessness, exacerbation frequency or lung function in chronic obstructive pulmonary disease (COPD). In mild-moderate disease and infrequent exacerbations, treatment risks may outweigh benefits and ICS may be withdrawn safely under...

Descripción completa

Detalles Bibliográficos
Autores principales: Cole, James N., Mathur, Rohini A., Hull, Sally A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395712/
https://www.ncbi.nlm.nih.gov/pubmed/32737296
http://dx.doi.org/10.1038/s41533-020-00191-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395712/
https://www.ncbi.nlm.nih.gov/pubmed/32737296
http://dx.doi.org/10.1038/s41533-020-00191-y

Ejemplares similares